What is the standard GLP-1 medication titration schedule?

How long should I stay on a starting dose of GLP-1 medication before increasing it?

**Starting doses on GLP-1 medications are designed to be temporary** — but "how long" depends on your medication, your tolerance, and what your provider has mapped out for you. **The standard titration schedules** Most GLP-1 medications come with built-in escalation timelines set by the manufacturer: - **Ozempic and Wegovy (semaglutide)** typically start at a lower dose for four weeks before stepping up - **Mounjaro and Zepbound (tirzepatide)** follow a similar four-week pattern at each dose level before advancing These aren't arbitrary — they exist to give your body time to adapt to slower gastric emptying and the other GI changes that come with GLP-1 therapy. **When it makes sense to stay longer** Your provider may recommend holding at a starting dose beyond the standard window if: - **Side effects are significant** — nausea, vomiting, or GI discomfort that hasn't settled down - **Tolerance hasn't stabilized** — your body may just need more runway - **Personal preference** — some people feel good at a lower dose and choose not to rush escalation **When titration might move faster** If you've tolerated the starting dose well and side effects are minimal, your provider may give the green light to advance on schedule or occasionally sooner. **The bottom line:** the four-week window is a starting point, not a hard rule. Dose escalation decisions belong in a conversation with your provider, who can weigh your tolerance, your progress, and your goals together. When in doubt, **talk to your provider** before advancing on your own.

What are the benefits of taking a lower dose of GLP-1 medication?

**Taking a lower dose of a GLP-1 medication isn't just a starting point** — for many people, it turns out to be a genuinely effective long-term strategy with real advantages worth understanding. **What lower doses can do:** - **Meaningful weight loss** is common even at starting doses — many people see results within the first month, well before any dose increase - **Appetite suppression and reduced cravings** kick in early, often at doses far below the maximum titration target - **Side effect burden stays lower** — nausea, GI disturbance, and fatigue are closely tied to dose level, and staying lower can mean a much smoother experience - **Metabolic improvements** — blood sugar, cholesterol, and related markers — can improve at lower doses independent of dramatic weight changes **Why some people stay lower on purpose:** Once a weight loss goal is reached, many people find that a reduced maintenance dose keeps results stable without pushing side effects. For those sensitive to GI effects, a lower dose may be the sweet spot where benefits outweigh discomfort. **What to keep in mind:** - Appetite suppression can plateau over time on the same dose, so staying at a lower level long-term may eventually require reassessment - Response varies a lot — some people do exceptionally well at lower doses indefinitely, while others need titration to see continued progress - Lower doses aren't a sign that the medication isn't "working" — they're a legitimate tool, not a consolation prize If you're wondering whether your current dose is the right fit for your goals, **talk to your provider** about what titration — or intentional dose maintenance — looks like for your specific situation.

What is the typical starting dose for GLP-1 medications?

**GLP-1 and GIP/GLP-1 medications always begin at a low starting dose** — and that's by design. The gradual ramp-up approach gives your body time to adjust, which helps minimize side effects like nausea as your dose increases over time. **Starting doses by medication:** - **Wegovy (semaglutide):** begins at 0.25 mg weekly for the first four weeks, then increases on a scheduled escalation toward the 2.4 mg maintenance dose - **Mounjaro (tirzepatide):** starts at 2.5 mg weekly for the first four weeks before stepping up - **Zepbound (tirzepatide):** same starting point as Mounjaro — 2.5 mg weekly — since both contain tirzepatide **Why the low start matters:** - **GI side effects** like nausea, constipation, and stomach discomfort are most common when doses increase too quickly - **Slow titration** lets your digestive system adapt to slower gastric emptying - **Effectiveness builds gradually** — most people reach a meaningful therapeutic dose after several months of escalation **How escalation works:** Dose increases typically happen every four weeks, though your provider may slow the schedule if side effects are significant. There's no rush — staying at a lower dose longer is always an option, and many people find a maintenance dose that works well before reaching the maximum. **What to expect early on:** Appetite changes can show up even at the starting dose, so don't be surprised if you notice effects right away. Side effects, if any, tend to be mild at 2.5 mg or 0.25 mg and often ease as your body adjusts. If you have questions about your specific escalation schedule, **talk to your provider** — dosing timelines can be personalized based on how you're tolerating the medication.

When should I reduce my GLP-1 dose due to severe side effects?

**Knowing when to reduce your GLP-1 dose** is one of the most important — and most confusing — parts of staying on track with treatment. The short answer: not every rough patch calls for a dose change, but some symptoms absolutely do. **Side effects that usually pass on their own:** - **Mild nausea or fatigue** during the first few weeks of a new dose level — these often settle as your body adjusts - **Low energy or light-headedness** that's manageable and improving over time - **Appetite suppression discomfort** from eating too much for your new hunger signals — this typically corrects with smaller meals **Symptoms that warrant a dose reduction (talk to your provider):** - **Persistent severe nausea or vomiting** that prevents you from eating or staying hydrated for more than a day or two - **Significant drops in blood pressure** or repeated fainting episodes, especially during dose escalation - **Debilitating fatigue** that isn't improving after several weeks at the same dose - **Any symptom that's interfering with daily functioning** and not showing signs of easing **Symptoms that need immediate care — not just a dose reduction:** - **Difficulty breathing, severe swelling**, or signs of an allergic reaction - **Chest pain, severe abdominal pain**, or symptoms that feel acute and alarming **A few things to keep in mind:** dose tolerance is highly individual — what one person breezes through can genuinely floor someone else at the same level. Escalating more slowly is often a better strategy than stopping altogether. When in doubt, **talk to your provider** before skipping or reducing doses on your own — they can help you find a pace that keeps side effects manageable without sacrificing your progress.